In recent years, we’ve seen some promising results for disease prevention in low-income countries. But, in during that same time, lower-middle income countries have been forgotten.
The lack of money for vaccinations in these countries has created new disease risks. Worse, the most common are the preventable diseases that pose little threat in other regions. This brings along with it a strong likelihood of future outbreaks if things don’t change.
But, what makes up a lower-middle income country?
Come flu season, every person of all ages is at risk of influenza. Every region across the world is susceptible to the contagious respiratory illness. Being different than a common cold, the flu can take effect suddenly and can range from mild to severe in illness.
While many sick with the flu tend to recover within two weeks, some people can develop complications.
One of those complications can lead to pneumonia. According to Everyday Health, one-third of pneumonia cases develop from a respiratory virus, with the flu the most common of those.
Many people likely weren’t familiar with monkeypox until September 2018 when major news broke from officials that the United Kingdom had its first ever case of monkeypox.
One month later, a total of three patients have been diagnosed in the country. Though further cases are unlikely, the incident has built up some concern. Travelers and healthcare workers alike worry of the deadly disease.
As epidemiology (the study and analysis of the various factors of health and disease events) shows us, knowledge is imperative to preventing the spread of many diseases. So, how did three people get the monkeypox virus in England in the first place? And what risk does the disease pose to people who may have been exposed to it?
Four new diseases pose a risk to travelers to tropical areas. The FDA recently added Lassa fever, chikungunya, rabies and cryptococcal meningitis to the Tropical Disease Priority List.
In a press release, the FDA’s Chief Scientist RADM Denise Hinton addressed the need for these additions. She noted that the list encourages new treatment for these diseases. By prioritizing them, we could see a push for new medicines or vaccines that could help the millions of people who live in these areas.
We’ve seen recent evidence of the effects these diseases can have on tropical regions.
In many parts of the world, yellow fever is no longer an issue. Yes, some parts of the world still have regular bouts with the disease, but medicine and vaccines have helped with that problem.
Although, not so long ago, the disease was responsible for terrible epidemics. People were forced to flee their homes with the fires still burning.
Scientists estimate that yellow fever originated in Africa around 3,000 B.C. It started with a smaller impact in local villages, growing in range to large cities.
